| 1. |
Z1-70012 |
Introducing PROTAKs: Evaluation of TAK1 chimeric degraders as a treatment option for rheumatoid arthritis |
5/1/2027
-
4/30/2029 |
PhD Nika Strašek Benedik
|
46 |
| 2. |
J3-70148 |
Alterations in host protein trafficking during Human papillomavirus infection and oncogenesis |
4/1/2026
-
3/31/2029 |
PhD Martina Bergant Marušič
|
1,875 |
| 3. |
J1-70053 |
Multitarget compounds with unexplored combination of activities for the treatment of Alzheimer's disease (MuTaCAD) |
4/1/2026
-
3/31/2029 |
PhD Stanislav Gobec
|
3,923 |
| 4. |
J3-70142 |
Charting new horizons: Unlocking the potential of NOD1, a versatile force in immunity |
3/1/2026
-
2/28/2029 |
PhD Žiga Jakopin
|
844 |
| 5. |
J3-70144 |
Development of new peptide therapies for the treatment of autoimmune and allergic diseases |
3/1/2026
-
2/28/2029 |
PhD Peter Korošec
|
3,740 |
| 6. |
J1-70052 |
Light-Driven Expansion of Chemical Space for Challenging Targets (LUX: BLI-AS-MS) |
3/1/2026
-
2/28/2029 |
PhD Janez Ilaš
|
1,740 |
| 7. |
J2-70087 |
Mimicking bone chemistry within injectable bone-filler: highly improved bioactivity for faster small defect regeneration |
3/1/2026
-
2/28/2029 |
PhD Marija Vukomanović
|
1,363 |
| 8. |
J1-70042 |
Neuroprotective and regenerative activity of γ-enolase as new therapeutic strategy in neuroinflammation-induced neurodegeneration |
3/1/2026
-
2/28/2029 |
PhD Anja Pišlar
|
3,035 |
| 9. |
J4-70164 |
Novel engineered protein nanoparticles to combat drug-resistant infections: oligolysins |
3/1/2026
-
2/28/2029 |
PhD Martina Durcik
|
768 |
| 10. |
J1-70043 |
Preclinical development of mitochondrial chaperone TRAP1 inhibitors as anticancer agents |
3/1/2026
-
2/28/2029 |
PhD Tihomir Tomašić
|
1,270 |
| 11. |
J1-70028 |
Prophage-induced cell wall modifications and their implications for antibiotic efficacy |
3/1/2026
-
2/28/2029 |
PhD Virginie Marie-Aline Grosboillot
|
1,578 |
| 12. |
J3-70137 |
Quality and safety of food supplements on the Slovenian market |
3/1/2026
-
2/28/2029 |
PhD Žane Temova Rakuša
|
1,181 |
| 13. |
J7-70266 |
Silver-111-labelled theranostic radiopharmaceuticals for CCK2R-expressing tumours – THERA.SI |
3/1/2026
-
2/28/2029 |
PhD Marko Anderluh
|
2,014 |
| 14. |
J1-70022 |
SMART-AD-DETECT: Pushing the Boundaries of Early Alzheimer’s Disease Detection |
3/1/2026
-
2/28/2029 |
PhD Jerneja Kladnik
|
2,653 |
| 15. |
J1-70040 |
Synthesis and evaluation of natural products caerulomycins as pharmaceutical agents or building blocks in metallodrug design (SynCAER) |
3/1/2026
-
2/28/2029 |
PhD Jakob Kljun
|
1,196 |
| 16. |
NK-60002 |
Development of Dual-Targeting hTOPOII/HDAC Split-and-Mix-PROTAC's |
1/1/2026
-
12/31/2028 |
PhD Janez Ilaš
|
285 |
| 17. |
N1-0417 |
Mono- and multivalent inhibitors of galectin-8 in tumour-associated (lymph)angiogenesis (MULTIGAL-8) |
3/1/2025
-
9/30/2028 |
PhD Marko Anderluh
|
893 |
| 18. |
Z1-70004 |
Development of Carbamoyl Fluorides as Warheads to Target Orphan Enzymes |
3/1/2026
-
2/29/2028 |
PhD Anže Meden
|
83 |
| 19. |
N1-0411 |
Two-photon-activated targeted cancer therapies |
3/1/2025
-
2/29/2028 |
PhD Anja Pišlar
|
1,327 |
| 20. |
BI-HU-26-27-002 |
Rational design of voltage-gated Na+ channel modulators |
1/1/2026
-
12/31/2027 |
|
0 |
| 21. |
BI-HU/26-27-002 |
Rational design of voltage-gated Na+ channel modulators |
1/1/2026
-
12/31/2027 |
|
0 |
| 22. |
J3-60066 |
Advanced post-neoadjuvant treatment of early triple negative breast cancer (TNBC) with autologous cell immunotherapy |
1/1/2025
-
12/31/2027 |
PhD Simona Borštnar
|
2,982 |
| 23. |
J1-60023 |
Boosting Our Resolve against Carbapenemase-Resistance with boron-containing therapeutics |
1/1/2025
-
12/31/2027 |
PhD Alen Krajnc
|
2,324 |
| 24. |
J3-60067 |
Cathepsin Targeted Immunotherapy for Pancreatic Cancer Treatment -CATIMMPACT |
1/1/2025
-
12/31/2027 |
PhD Milica Perišić Nanut
|
2,361 |
| 25. |
J3-60060 |
Extracellular vesicles from recombinant Lactococcus lactis as novel protein delivery vectors for treatment of intestinal inflammation and prevention of colorectal cancer |
1/1/2025
-
12/31/2027 |
PhD Tina Vida Plavec
|
1,299 |
| 26. |
J2-60047 |
Magnetic micro-structuring of the Mg alloy surfaces for improved endothelialization and retained degradability of vascular stent materials |
1/1/2025
-
12/31/2027 |
PhD Slavko Kralj
|
3,747 |
| 27. |
N1-0331 |
A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases |
1/1/2024
-
12/31/2027 |
PhD Izidor Sosič
|
1,172 |
| 28. |
BI-JP-25-27-004 |
Synovial stem cells as treatment tools for degenerative joint diseases and injuries |
4/1/2025
-
3/31/2027 |
|
0 |
| 29. |
BI-JP/25-27-004 |
Synovial stem cells as treatment tools for degenerative joint diseases and injuries |
4/1/2025
-
3/31/2027 |
PhD Janja Zupan
|
152 |
| 30. |
N1-0363 |
Bisphenol A substitutes: health risks to the endocrine and cardiovascular systems (Acronim: BPAsubRisk) |
3/1/2024
-
2/28/2027 |
PhD Marija Sollner Dolenc
|
1,862 |
| 31. |
BI-NO-25-27-006 |
Evaluation of academic libraries to develop new antibacterial compounds |
1/1/2025
-
12/31/2026 |
|
0 |
| 32. |
BI-NO/25-27-006 |
Evaluation of academic libraries to develop new antibacterial compounds |
1/1/2025
-
12/31/2026 |
PhD Rok Frlan
|
131 |
| 33. |
BI-VB-25-27-002 |
Tackling carbapenemase-mediated resistance to beta-lactam antibiotics |
1/1/2025
-
12/31/2026 |
|
0 |
| 34. |
BI-VB/25-27-002 |
Tackling carbapenemase-mediated resistance to beta-lactam antibiotics |
1/1/2025
-
12/31/2026 |
PhD Alen Krajnc
|
44 |
| 35. |
J1-50038 |
New Hsp90 Inhibitor-based Therapies for Ewing Sarcoma |
1/1/2024
-
12/31/2026 |
PhD Tihomir Tomašić
|
1,279 |
| 36. |
J1-50023 |
3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation |
10/1/2023
-
9/30/2026 |
PhD Andrej Emanuel Cotman
|
1,266 |
| 37. |
J3-50099 |
A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking |
10/1/2023
-
9/30/2026 |
PhD Peter Korošec
|
1,844 |
| 38. |
J3-50123 |
Bacterial Biofilm Formation Inhibitors: A Novel Approach to Combat Antimicrobial Resistance |
10/1/2023
-
9/30/2026 |
PhD Martina Hrast Rambaher
|
2,699 |
| 39. |
J1-50039 |
Breaking the Walls: Development of Inhibitors of D,D- and L,D-Transpeptidases |
10/1/2023
-
9/30/2026 |
PhD Stanislav Gobec
|
4,362 |
| 40. |
J1-50037 |
Development of CDK1-selective degraders for the treatment of T-cell malignancies |
10/1/2023
-
9/30/2026 |
PhD Izidor Sosič
|
1,367 |
| 41. |
L7-50044 |
Efficacy and safety of dietary supplementation in targeting sleep quality: an evidence-based approach for supporting informed choices |
10/1/2023
-
9/30/2026 |
PhD Igor Pravst
|
4,169 |
| 42. |
J3-50116 |
Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors |
10/1/2023
-
9/30/2026 |
PhD Martina Gobec
|
2,531 |
| 43. |
J4-50139 |
Valorization of Himalayan balsam (Impatiens glandulifera Royle) waste to design bioactive extracts with a potential protective activity on the human vascular system |
10/1/2023
-
9/30/2026 |
PhD Alen Albreht
|
1,543 |
| 44. |
J7-4635 |
MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy |
10/1/2022
-
9/30/2026 |
PhD Lucija Peterlin Mašič
|
6,985 |
| 45. |
J3-4496 |
Next-generation adjuvants for mucosal vaccines |
10/1/2022
-
9/30/2026 |
PhD Žiga Jakopin
|
1,538 |
| 46. |
BI-US-24-26-098 |
Mechanistic characterization of protein degraders with anti-cancer activity |
7/1/2024
-
6/30/2026 |
|
0 |
| 47. |
BI-US/24-26-098 |
Mechanistic characterization of protein degraders with anti-cancer activity |
7/1/2024
-
6/30/2026 |
PhD Izidor Sosič
|
302 |
| 48. |
BI-US/24-26-032 |
Periphery in the center: Inclusion and exclusion of anthropology researchers in leading international scientific activities |
7/1/2024
-
6/30/2026 |
PhD Dan Podjed
|
749 |
| 49. |
BI-US-24-26-069 |
Structure-based discovery of new small molecule Hv1 proton channel inhibitors |
7/1/2024
-
6/30/2026 |
|
0 |
| 50. |
BI-US/24-26-069 |
Structure-based discovery of new small molecule Hv1 proton channel inhibitors |
7/1/2024
-
6/30/2026 |
PhD Nace Zidar
|
269 |
| 51. |
BI-US-24-26-033 |
Unraveling Hsp90 inhibitor binding modes for rational anticancer drug design |
7/1/2024
-
6/30/2026 |
|
0 |
| 52. |
BI-US/24-26-033 |
Unraveling Hsp90 inhibitor binding modes for rational anticancer drug design |
7/1/2024
-
6/30/2026 |
PhD Tihomir Tomašić
|
458 |
| 53. |
BI-FR-24-25-PROTEUS-003 |
Poplačilo obveznosti za leto 2025: Antibiotični adjuvansi: translokacija bor-vsebujočih zaviralcev β-laktamaz preko porinskih kanalov OmpF/OmpC in subcelična kvantifikacija le-teh v Enterobakterijah (Slovene) |
1/1/2025
-
5/31/2026 |
|
0 |
| 54. |
BI-FR-24-25-PROTEUS-002 |
Poplačilo obveznosti za leto 2025: Identifikacija nizkomolekularnih zaviralcev za razvoj novih protibakterijskih zdravil (Slovene) |
1/1/2025
-
5/31/2026 |
|
0 |
| 55. |
BI-JP/24-26-003 |
Structure-based discovery of novel Hv1 proton channel inhibitors |
4/1/2024
-
4/1/2026 |
PhD Nace Zidar
|
269 |
| 56. |
BI-JP-24-26-003 |
Structure-based discovery of novel Hv1 proton channel inhibitors |
4/1/2024
-
3/31/2026 |
|
0 |
| 57. |
BI-FR/24-25-PROTEUS-003 |
Antibiotic adjuvants – Translocation of novel (cyclic boron-based) β-lactamase inhibitors across OmpF/OmpC porin channels and subcellular quantification of in enterobacteria |
1/1/2025
-
12/31/2025 |
PhD Alen Krajnc
|
44 |
| 58. |
BI-FR/24-25-PROTEUS-002 |
Identification of small molecule inhibitors for the development of new antibacterial drugs |
1/1/2025
-
12/31/2025 |
PhD Rok Frlan
|
131 |
| 59. |
BI-FR/24-25-PROTEUS-003 |
Antibiotic adjuvants: translocation of boron-containing β-lactamase inhibitors via OmpF/OmpC porin channels and their subcellular quantification in Enterobacteria |
1/1/2024
-
12/31/2025 |
PhD Alen Krajnc
|
44 |
| 60. |
BI-FR/24-25-PROTEUS-002 |
Identification of low molecular weight inhibitors for the development of new antibacterial drugs |
1/1/2024
-
12/31/2025 |
PhD Rok Frlan
|
131 |
| 61. |
BI-RS/23-25-016 |
Confronting multidrug-resistant Acinetobacter baumanii infection by DNA gyrase and topoisomerase inhibitors |
7/1/2023
-
12/31/2025 |
PhD Žiga Jakopin
|
228 |
| 62. |
BI-RS/23-25-018 |
The use of active cosmetic ingredients from botanical origin for lowering the synthetic preserves in cosmetic products |
7/1/2023
-
12/31/2025 |
PhD Samo Kreft
|
802 |
| 63. |
N1-0277 |
Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease |
1/1/2023
-
12/31/2025 |
PhD Stanislav Gobec
|
1,445 |
| 64. |
J3-3079 |
Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms |
12/1/2021
-
11/30/2025 |
PhD Stane Pajk
|
2,993 |
| 65. |
L4-4564 |
Biotehnological potential of selected microorganisms from Sečovlje Saltpans for application in cosmetics products |
10/1/2022
-
9/30/2025 |
PhD Ana Rotter
|
3,237 |
| 66. |
J1-4417 |
Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy |
10/1/2022
-
9/30/2025 |
PhD Matej Sova
|
4,456 |
| 67. |
J1-4402 |
Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors |
10/1/2022
-
9/30/2025 |
PhD Andrej Perdih
|
3,002 |
| 68. |
J1-4400 |
Evaluation of transient protein states |
10/1/2022
-
9/30/2025 |
PhD Simona Golič Grdadolnik
|
3,617 |
| 69. |
J3-4499 |
MECHANISMS OF RESPONSE TO INTERLEUKIN 12/23 BLOCKERS IN ULCERATIVE COLITS – TOWARDS PERSONALIZED MEDICINE |
10/1/2022
-
9/30/2025 |
PhD David Drobne
|
2,862 |
| 70. |
J3-4527 |
Muscle cell secretom and bone cells interplay in osteosarcopenia (MiKOSA) |
10/1/2022
-
9/30/2025 |
PhD Janja Marc
|
4,007 |
| 71. |
J7-4418 |
Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections |
10/1/2022
-
9/30/2025 |
PhD Špela Zupančič
|
6,117 |
| 72. |
J4-4556 |
New biofertilization approach based on the microbial multispecies biocatalytic aggregates |
10/1/2022
-
9/30/2025 |
PhD Tomaž Rijavec
|
7,140 |
| 73. |
J1-4414 |
ProBiS-Fold approach for binding site detection for whole structural human proteome in drug discovery |
10/1/2022
-
9/30/2025 |
PhD Dušanka Janežič
|
2,358 |
| 74. |
L2-4455 |
Quantitative light scattering spectroscopy as a process analytical technology in pharmaceutical manufacturing |
10/1/2022
-
9/30/2025 |
PhD Franjo Pernuš
|
2,801 |
| 75. |
J2-4480 |
Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma) |
10/1/2022
-
9/30/2025 |
PhD Martin Petkovšek
|
3,248 |
| 76. |
J7-4420 |
Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles |
10/1/2022
-
9/30/2025 |
PhD Aleš Berlec
|
4,474 |
| 77. |
J3-3062 |
Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer |
10/1/2021
-
9/30/2025 |
PhD Matjaž Jeras
|
2,825 |
| 78. |
J1-3031 |
Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance |
10/1/2021
-
9/30/2025 |
PhD Nace Zidar
|
1,215 |
| 79. |
J2-3043 |
Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases |
10/1/2021
-
9/30/2025 |
PhD Slavko Kralj
|
5,071 |
| 80. |
J1-3030 |
MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance |
10/1/2021
-
9/30/2025 |
PhD Lucija Peterlin Mašič
|
1,121 |
| 81. |
BI-HR/23-24-031 |
Development of nanomedicines with poorly soluble drugs for ocular application |
4/1/2023
-
3/31/2025 |
PhD Petra Kocbek
|
331 |
| 82. |
BI-HR/23-24-032 |
Evaluation of harmine analogues as potential Hsp90 inhibitors against pediatric sarcomas |
4/1/2023
-
3/31/2025 |
PhD Tihomir Tomašić
|
458 |
| 83. |
J3-3071 |
Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy |
10/1/2021
-
3/31/2025 |
PhD Ana Mitrović
|
2,928 |
| 84. |
BI-TR/22-24-007 |
Antimicrobial activity evaluation of natural and synthetic cinnamic acid derivatives against human and fish pathogens and their potential use as additives in fish feed |
1/1/2023
-
12/31/2024 |
PhD Matej Sova
|
178 |
| 85. |
BI-DE/23-24-011 |
Computer-aided design, synthesis and biological evaluation of Toll-like receptor 8 modulators |
1/1/2023
-
12/31/2024 |
PhD Matej Sova
|
178 |
| 86. |
BI-FR/23-24-PROTEUS-002 |
Development of effective reactivators of organophosphate-inhibited butyrylcholinesterase |
1/1/2023
-
12/31/2024 |
PhD Damijan Knez
|
284 |
| 87. |
BI-AT/23-24-008 |
Development of Hsp90 C-terminal domain inhibitors for the treatment of pediatric sarcomas |
1/1/2023
-
12/31/2024 |
PhD Tihomir Tomašić
|
458 |
| 88. |
BI-DE/23-24-009 |
New mitochondrial ion channels Kv1.3 inhibitors as inducers of apoptosis |
1/1/2023
-
12/31/2024 |
PhD Lucija Peterlin Mašič
|
449 |
| 89. |
BI-ME/23-24-030 |
Non-Alcoholic Fatty Liver Disease in adolescents and its association with oxidative stress, inflammation and genetic factors |
1/1/2023
-
12/31/2024 |
PhD Barbara Ostanek
|
213 |
| 90. |
L3-3177 |
Safety evaluation of cannabidiols and implications for public health and consumers behaviour |
10/1/2021
-
12/31/2024 |
PhD Alja Štern
|
5,314 |
| 91. |
Z1-4405 |
Development of new antibiotics simultaneously targeting beta-lactamases and penicillin-binding proteins |
10/1/2022
-
9/30/2024 |
PhD Alen Krajnc
|
44 |
| 92. |
J1-3021 |
A synthetic biofilm-based platform for studying and development of new antibiofilm strategies |
10/1/2021
-
9/30/2024 |
PhD Iztok Dogša
|
1,608 |
| 93. |
J4-3092 |
Development of biologically active and chemically stable xanthophylls based on a sustainable esterification of xanthophylls from renewable natural resources |
10/1/2021
-
9/30/2024 |
PhD Alen Albreht
|
1,539 |
| 94. |
L1-3160 |
Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration |
10/1/2021
-
9/30/2024 |
PhD Iztok Grabnar
|
3,355 |
| 95. |
J4-3096 |
Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile |
10/1/2021
-
9/30/2024 |
PhD Borut Štrukelj
|
3,509 |
| 96. |
J1-3018 |
Smart probes for ex vivo assay-based early prediction of Alzheimer disease |
10/1/2021
-
9/30/2024 |
PhD Janez Košmrlj
|
2,538 |
| 97. |
L3-3176 |
The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID-
19 Disease |
10/1/2021
-
9/30/2024 |
PhD Janja Zupan
|
3,768 |
| 98. |
BI-US/22-24-182 |
Characterization of NOD2 receptor ligand binding |
7/1/2022
-
6/30/2024 |
PhD Žiga Jakopin
|
228 |
| 99. |
BI-US/22-24-004 |
Optimization of selective butyrylcholine esterase inhibitors as potential therapeutic agents for heroin abuse therapy |
7/1/2022
-
6/30/2024 |
PhD Damijan Knez
|
284 |
| 100. |
N1-0172 |
Fotokemijski pristop za odkrivanje naprednih ATP-kompetitivnih prob z zaviralnim delovanjem na Topoizomerazo IIalfa (Slovene) |
1/1/2021
-
12/31/2023 |
PhD Janez Ilaš
|
863 |
| 101. |
N1-0169 |
Kovalentni pristop k boju proti bakterijski rezistenci (Slovene) |
1/1/2021
-
12/31/2023 |
PhD Stanislav Gobec
|
1,388 |
| 102. |
J3-2517 |
Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants |
9/1/2020
-
12/31/2023 |
PhD Žiga Jakopin
|
2,575 |
| 103. |
J1-2484 |
Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis |
9/1/2020
-
8/31/2023 |
PhD Stanislav Gobec
|
4,304 |
| 104. |
J7-2603 |
EFFICACY OF BACTERIOPHAGES FOR TREATEMENT OF EXTRACELULAR AND INTRACELULAR BACTERIAL INFECTIONS OF IMPLANTANTS |
9/1/2020
-
8/31/2023 |
PhD Aleš Podgornik
|
2,534 |
| 105. |
J3-2521 |
Inflammatory process in interstitial cystitis and evaluation of the influence of cannabinoid receptor agonists in urinary bladder - from cells to patients |
9/1/2020
-
8/31/2023 |
PhD Peter Veranič
|
4,229 |
| 106. |
J1-2483 |
Radiopharmaceuticals with antagonistic activity on CCK2R |
9/1/2020
-
8/31/2023 |
PhD Marko Anderluh
|
1,235 |
| 107. |
J3-2518 |
Role of APOBEC proteins in the oncogenesis of HPV viruses |
9/1/2020
-
8/31/2023 |
PhD Martina Bergant Marušič
|
1,395 |
| 108. |
J1-2485 |
The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs |
9/1/2020
-
8/31/2023 |
PhD Izidor Sosič
|
1,172 |
| 109. |
J1-1717 |
Development of novel Hsp90 inhibitors with anticancer activity |
7/1/2019
-
6/30/2023 |
PhD Tihomir Tomašić
|
2,148 |
| 110. |
J3-1745 |
Elucidating the role of immunoproteasome in platelet-driven immune response |
7/1/2019
-
6/30/2023 |
PhD Martina Gobec
|
1,313 |
| 111. |
J3-1749 |
Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system |
7/1/2019
-
6/30/2023 |
PhD Janja Zupan
|
2,636 |
| 112. |
J1-1709 |
Strukturni vpogled v mehanizem tvorbe površine bakterije Clostridium difficile |
7/1/2019
-
6/30/2023 |
PhD Dušan Turk
|
2,162 |
| 113. |
J4-1778 |
Exploitation of a virus-borne small protein to combat antibiotic resistance in Staphylococcus aureus |
7/1/2019
-
12/31/2022 |
PhD Matej Butala
|
3,751 |
| 114. |
N1-0098 |
Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity |
1/1/2019
-
12/31/2022 |
PhD Lucija Peterlin Mašič
|
1,023 |
| 115. |
V4-2038 |
DNA vaccine and peptide inhibitors against SARS-CoV-2 |
10/1/2020
-
9/30/2022 |
PhD Roman Jerala
|
8,986 |
| 116. |
Z1-2635 |
Modular asymmetric total synthesis of bioactive multi-chiral natural products |
9/1/2020
-
8/31/2022 |
PhD Andrej Emanuel Cotman
|
90 |
| 117. |
J3-1759 |
Comprehensive characterization of GWAS hits – pipeline to novel drug targets for anabolic treatment of osteoporosis
(GWASforAna) |
7/1/2019
-
6/30/2022 |
PhD Janja Marc
|
5,413 |
| 118. |
J4-1776 |
Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F |
7/1/2019
-
6/30/2022 |
PhD Janko Kos
|
3,418 |
| 119. |
J1-1715 |
Protein interaction atlas for prediction of genetic variations involved in drug interactions and disease development |
7/1/2019
-
6/30/2022 |
PhD Dušanka Janežič
|
2,898 |
| 120. |
J4-1767 |
Selective extraction of high value molecules from forest products processing residues in the
speciality chemicals sector |
7/1/2019
-
6/30/2022 |
PhD Andreja Kutnar
|
4,536 |
| 121. |
J3-9256 |
Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants |
7/1/2018
-
6/30/2022 |
PhD Žiga Jakopin
|
3,194 |
| 122. |
J1-9194 |
Nanomedicines with antibiotics and probiotics for local treatment of periodontal disease |
7/1/2018
-
6/30/2022 |
PhD Julijana Kristl
|
3,880 |
| 123. |
Z1-1859 |
Targeted covalent inhibitors: inhibiting monoamine oxidase through non-catalytic amino-acid residues |
7/1/2019
-
6/30/2021 |
PhD Damijan Knez
|
284 |
| 124. |
J3-9267 |
Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease |
7/1/2018
-
6/30/2021 |
PhD Anja Pišlar
|
3,094 |
| 125. |
J1-9192 |
New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors
|
7/1/2018
-
6/30/2021 |
PhD Lucija Peterlin Mašič
|
2,542 |
| 126. |
J4-9327 |
Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria |
7/1/2018
-
6/30/2021 |
PhD Aleš Berlec
|
2,714 |
| 127. |
NC-0009 |
Development of new carbamate-based imaging probes for cholinesterases |
4/1/2019
-
3/31/2021 |
PhD Stanislav Gobec
|
1,187 |
| 128. |
V1-1914 |
Izbor in priprava dosjeja potencialno nevrotoksične kemikalije z uporabo in-silico metod za namen izvajanja evropske kemijske zakonodaje REACH (Slovene) |
11/1/2019
-
10/31/2020 |
PhD Marjan Vračko - Grobelšek
|
988 |
| 129. |
N1-0068 |
Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods |
11/1/2017
-
10/31/2020 |
PhD Stanislav Gobec
|
2,137 |
| 130. |
Z1-9195 |
Butyrylcholinesterase inhibitors for alleviating symptoms of Alzheimer's disease |
7/1/2018
-
6/30/2020 |
PhD Urban Košak
|
76 |
| 131. |
NC-0004 |
NOBIL - Novel Biomarkers in Leukemia |
5/1/2018
-
4/30/2020 |
PhD Irena Mlinarič Raščan
|
894 |
| 132. |
J1-8145 |
Dinamični vidik vezave ligandov na proteine (Slovene) |
5/1/2017
-
4/30/2020 |
PhD Simona Golič Grdadolnik
|
2,013 |
| 133. |
J1-8140 |
Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene) |
5/1/2017
-
4/30/2020 |
PhD Metka Filipič
|
4,217 |
| 134. |
J1-8152 |
Inhibicija prenove celične stene Staphylococus aureus (Slovene) |
5/1/2017
-
4/30/2020 |
PhD Dušan Turk
|
2,267 |
| 135. |
J3-8207 |
Novi izzivi folatne terapije v porodništvu in ginekologiji (Slovene) |
5/1/2017
-
4/30/2020 |
PhD Ksenija Geršak
|
5,353 |
| 136. |
J3-8210 |
Potencial nizkih, sub-terapevtskih odmerkov statinov in sartanov v primarni in sekundarni preventivi src?no-z?ilnih bolezni (Slovene) |
5/1/2017
-
4/30/2020 |
PhD Mirza Šabovič
|
2,657 |
| 137. |
J4-8227 |
Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene) |
5/1/2017
-
4/30/2020 |
PhD Janko Kos
|
5,275 |
| 138. |
L1-8157 |
Razvoj multifunkcionalnih učinkovin za zdravljenje Alzheimerjeve bolezni (Slovene) |
5/1/2017
-
4/30/2020 |
PhD Stanislav Gobec
|
5,139 |
| 139. |
V4-1605 |
The use of hop products for organic control of varroa (Varroa destructor) |
10/1/2016
-
9/30/2019 |
PhD Iztok Jože Košir
|
3,367 |
| 140. |
Z1-8158 |
Discovery of new inhibitors of bacterial peptidoglycan biosynthesis enzymes MurA and MurB |
5/1/2017
-
4/30/2019 |
PhD Marko Jukič
|
212 |
| 141. |
L2-7550 |
Elecrospun nanofibrous materials for solid state drug delivery system |
3/1/2016
-
2/28/2019 |
PhD Igor Emri
|
4,843 |
| 142. |
J4-7640 |
Electrostatic immobilisation of bacterial cells and effects on their physiology |
3/1/2016
-
2/28/2019 |
PhD Aleš Lapanje
|
7,730 |
| 143. |
J3-7245 |
Identification of new expression regulators of RANKL, a key molecule not only in bone remodelling |
1/1/2016
-
12/31/2018 |
PhD Janja Marc
|
2,914 |
| 144. |
J1-7302 |
Nanotheranostics based on magneto-responsive materials |
1/1/2016
-
12/31/2018 |
PhD Petra Kocbek
|
4,427 |
| 145. |
J1-7515 |
Receptors for toxins of plant pathogens |
1/1/2016
-
12/31/2018 |
PhD Gregor Anderluh
|
4,203 |
| 146. |
J1-7479 |
Structural insight into iodine metabolism |
1/1/2016
-
12/31/2018 |
PhD Dušan Turk
|
2,005 |
| 147. |
J3-7494 |
Tunneling nanotubes for innovative urinary bladder cancer treatments |
1/1/2016
-
12/31/2018 |
PhD Mateja Erdani Kreft
|
7,884 |
| 148. |
V3-1636 |
Sistem odkrivanja novih psihoaktivnih snovi v Sloveniji (akronim SONDA) (Slovene) |
10/1/2016
-
9/30/2018 |
PhD Miran Brvar
|
1,660 |
| 149. |
Z1-7181 |
Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer |
1/1/2016
-
12/31/2017 |
PhD Izidor Sosič
|
302 |
| 150. |
L1-6745 |
Boj proti bakterijski rezistenci: optimizacija zaviralcev biosinteze bakterijske stene (Slovene) |
7/1/2014
-
6/30/2017 |
PhD Stanislav Gobec
|
3,615 |
| 151. |
J1-6746 |
Nanozdravila za zdravljenje parodontalne bolezni s ciljanim vnosom v obzobne žepe (Slovene) |
7/1/2014
-
6/30/2017 |
PhD Julijana Kristl
|
4,267 |
| 152. |
J1-6744 |
Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bio-analitike (Slovene) |
7/1/2014
-
6/30/2017 |
PhD Tina Kosjek
|
5,480 |
| 153. |
J1-6743 |
Razvoj računalniških orodij za modeliranje farmacevtsko zanimivih molekul (Slovene) |
7/1/2014
-
6/30/2017 |
PhD Dušanka Janežič
|
3,089 |
| 154. |
J3-6792 |
TRANS TIO Translacijske farmakogenomske raziskave tiopurinske terapije (Slovene) |
7/1/2014
-
6/30/2017 |
PhD Irena Mlinarič Raščan
|
1,791 |
| 155. |
J4-6811 |
Vloga inhibitorjev cisteinskih proteaz v citotoksičnem delovanju naravnih celic ubijalk na tumorske celice (Slovene) |
7/1/2014
-
6/30/2017 |
PhD Janko Kos
|
2,889 |
| 156. |
J3-5507 |
ANALIZA BIOLOŠKIH OZNAČEVALCEV PRESNOVE FOLATOV PRI UGOTAVLJANJU TVEGANJA ZA NASTANEK NAPAK NEVRALNE CEVI (Slovene) |
8/1/2013
-
7/31/2016 |
PhD Ksenija Geršak
|
3,943 |
| 157. |
J3-5511 |
Mikro RNA - nove diagnostične in terapevtske tarče pri osteoporozi (Slovene) |
8/1/2013
-
7/31/2016 |
PhD Janez Preželj
|
1,839 |
| 158. |
J3-5502 |
Napake v regulaciji izražanja TDP-43 pri amiotrofični lateralni sklerozi in frontotemporlani lobarni degeneraciji (Slovene) |
8/1/2013
-
7/31/2016 |
PhD Boris Rogelj
|
5,751 |
| 159. |
J4-5529 |
Nitroksolin in njegovi derivati kot nova protitumorska zdravila (Slovene) |
8/1/2013
-
7/31/2016 |
PhD Janko Kos
|
6,805 |
| 160. |
J1-5450 |
Proteinsko načrtovanje rekombinantnih probiotičnih mlečnokislinskih bakterij za zdravljenje sindromov vnetega črevesa (Slovene) |
8/1/2013
-
7/31/2016 |
PhD Borut Štrukelj
|
2,660 |
| 161. |
Z1-5458 |
Design, synthesis, and evaluation of new voltage-gated sodium channels modulators |
8/1/2013
-
7/31/2015 |
PhD Nace Zidar
|
269 |
| 162. |
J4-4123 |
Inhibitorji cisteinskih karboksipeptidaz kot regulatorji avtoimunskih in nevrodegenerativnih procesov (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Janko Kos
|
7,106 |
| 163. |
L2-4072 |
Kompleksni hiperspektralni sistem za avtomatsko analiziranje in vodenje procesov oblaganja farmacevtskih pelet (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Boštjan Likar
|
2,413 |
| 164. |
J1-4236 |
Načrtovanje, izdelava in vrednotenje biomimetičnih nanokompozitnih sistemov za učinkovito obnovo tkiv (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Julijana Kristl
|
5,371 |
| 165. |
L1-4039 |
Predklinični razvoj novih protimikrobnih učinkovin (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Stanislav Gobec
|
4,652 |
| 166. |
J3-4285 |
Razvoj in ovrednotenje radiooznačenih bioloških molekul za ciljano radionuklidno terapijo nevroendokrinih tumorjev in spremljajočo diagnostiko (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Jurij Fettich
|
2,542 |
| 167. |
L6-4045 |
Teoretični in praktični vidiki terminologije in terminografije v povezavi s spletnimi terminološkimi viri (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Andreja Žele
|
4,342 |
| 168. |
J3-4026 |
Transport in RNA vezava proteinov TDP-43 in FUS - implikacije za ALS/FTLD spekter nevrodegenerativnih bolezni (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Boris Rogelj
|
5,109 |
| 169. |
J3-4220 |
Vloga genetskih polimorfizmov na izid zdravljenja in pojav zapletov pri otrocih z rakom (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Janez Jazbec
|
3,766 |
| 170. |
J3-4313 |
Vpliv aktivnega transporta imatiniba in različnih genotipov pacientov na uspešnost terapije kronične mieloične levkemije (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Albin Kristl
|
3,388 |
| 171. |
J3-3615 |
Farmakogenetski pristop k raziskavam, diagnostiki in terapiji levkemij (Slovene) |
5/1/2010
-
4/30/2013 |
PhD Irena Mlinarič Raščan
|
2,371 |
| 172. |
J3-2330 |
Genetski dejavniki pri osteoporozi (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Janja Marc
|
2,550 |
| 173. |
J4-2212 |
Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Nada Kraševec
|
3,980 |
| 174. |
J3-2356 |
Izrazanje in funkcionalna analiza nekodirajocih RNA pri parkinsonovi bolezni (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Boris Rogelj
|
4,769 |
| 175. |
L3-2293 |
Zaščitni pleiotropni učinki nizkih odmerkov zaviralcev sistema renin-angiotenzin in statinov pri zdravi populaciji srednjih let (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Mirza Šabovič
|
4,075 |
| 176. |
J3-0488 |
FUNKCIONALNA ANALIZA NEKODIRAJOČIH RNA PRI PARKINSONOVI BOLEZNI (Slovene) |
2/1/2008
-
1/31/2011 |
PhD Boris Rogelj
|
2,525 |
| 177. |
L3-0431 |
GENETIKA RAKA DOJK IN HORMOSNKO NADOMESTNO ZDRAVLJENJE (Slovene) |
2/1/2008
-
1/31/2011 |
PhD Ksenija Geršak
|
3,979 |
| 178. |
L3-0129 |
IZVENCELIČNE NUKLEINSKE KISLINE V DIAGNOSTIKI KORONARNE ATEROSKLEROZE (Slovene) |
2/1/2008
-
1/31/2011 |
PhD Darko Černe
|
2,151 |
| 179. |
L4-1046 |
Nove zdravilne učinkovine biotehnološkega izvora z uporabo bakteriofagnega prikaza (Slovene) |
2/1/2008
-
1/31/2011 |
PhD Borut Štrukelj
|
4,445 |
| 180. |
L3-0636 |
PRIPRAVA IN EVALVACIJA STABILIZIRANE KONTROLNE KRVI ZA HEMOGRAM IN DIFERENCIALNO BELO KRVNO SLIKO ZA HEMATOLOŠKE ANALIZATORJE ZA POTREB (Slovene) |
2/1/2008
-
1/31/2011 |
PhD Milan Skitek
|
1,192 |
| 181. |
L6-0075 |
Slovenska terminologija v povezavi s spletnimi jezikovnimi viri (Slovene) |
2/1/2008
-
1/31/2011 |
PhD Andreja Žele
|
3,096 |
| 182. |
J7-0337 |
Formulation and characterization of fuzogenic colloidal nanoparticles for efficient drug delivery into cells |
2/1/2008
-
1/30/2011 |
PhD Marjeta Šentjurc
|
1,690 |
| 183. |
J7-0474 |
New Report on Condition of Knowledge in Developed Societies – 30 Years after Jean-François Lyotard’s Analysisew Report on Knowledge |
2/1/2008
-
1/30/2011 |
PhD Mladen Dolar
|
3,290 |
| 184. |
J1-0957 |
Pharmacogenetic study of raloxifene metabolism and transport |
2/1/2008
-
1/30/2011 |
PhD Aleš Mrhar
|
2,082 |
| 185. |
J7-9704 |
NQR - nondestructive method for studying of polymorphism in heteregeneous pharmaceutical systems |
7/1/2007
-
6/30/2010 |
PhD Zvonko Trontelj
|
4,877 |
| 186. |
J4-9425 |
Lektini kot modulatorji protitumorskega imunskega odziva (Slovene) |
1/1/2007
-
12/31/2009 |
PhD Janko Kos
|
2,417 |
| 187. |
J4-7062 |
Proteomics as a tool for monitoring biosynthesis processes |
9/1/2005
-
8/31/2008 |
PhD Janko Kos
|
6,313 |
| 188. |
J1-7363 |
Role of the proteolytic systems in the malignancy of brain tumour stem cells. |
9/1/2005
-
8/31/2008 |
PhD Irena Zajc
|
3,635 |
| 189. |
J3-7406 |
Thiopurine pharmacogenetics
- novel diagnostics and individualized therapy |
9/1/2005
-
8/31/2008 |
PhD Irena Mlinarič Raščan
|
2,789 |
| 190. |
M4-0124 |
Prehranski dodatki za optimalno prehrano v ekstremnih razmerah (Slovene) |
6/1/2006
-
11/30/2007 |
PhD Samo Kreft
|
4,260 |
| 191. |
J3-6429 |
Genetski dejavniki reproduktivnega zdravja ženske (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Ksenija Geršak
|
3,597 |
| 192. |
J1-6356 |
Use of inorganic particles for particle design and their potential application in systems with modified release |
7/1/2004
-
6/30/2007 |
PhD Marjan Bele
|
2,857 |
| 193. |
L1-6707 |
Design, synthesis and test of potencial hypolipidemic drugs with a new target |
2/1/2004
-
1/30/2007 |
PhD Uroš Urleb
|
3,665 |
| 194. |
L1-6711 |
Development of a technological procedure for preparation of biologicaly active hop extract enriched with xanthohumol |
7/1/2004
-
6/30/2006 |
PhD Tamara Lah Turnšek
|
6,323 |
| 195. |
Z1-6451 |
Mehanizem povečanja permeabilnosti sečnega mehurja s hitosanom (Slovene) |
7/1/2004
-
6/30/2006 |
PhD Danijel Kikelj
|
862 |
| 196. |
Z4-6096 |
Peptide ligands as novel biopharmaceutics by using phage display technology |
2/1/2004
-
1/30/2006 |
PhD Borut Štrukelj
|
1,398 |
| 197. |
L1-5267 |
Analysis of gene expression associated with apoptosis using microarrays |
1/1/2003
-
12/31/2005 |
PhD Irena Mlinarič Raščan
|
781 |
| 198. |
L3-5309 |
Analysis of gene expression associated with apoptosis using microarrays |
1/1/2003
-
12/31/2005 |
PhD Irena Mlinarič Raščan
|
1,210 |
| 199. |
L1-5094 |
Determination of surface properties of solid and semisolid materials by solid and semisolid materials with inverse phase gas chromatography |
1/1/2003
-
12/31/2005 |
PhD Stanko Srčič
|
2,957 |
| 200. |
L3-5084 |
Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene) |
1/1/2003
-
12/31/2005 |
PhD Mojca Stegnar
|
5,883 |
| 201. |
L4-4090 |
Optimizacija kakovosti zdravilnih rastlin (Echinacea purpurea Moench., Gentiana lutea L., Hypericum perforatum L.) v pridelovanju (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Dea Baričevič
|
2,526 |
| 202. |
Z1-3238 |
Genetic and environmental risk factors for bone remodelation disturbances |
7/1/2001
-
6/30/2004 |
PhD Samo Kreft
|
2,162 |
| 203. |
J3-3395 |
Genetic causes of female infertility 2
|
7/1/2001
-
6/30/2004 |
PhD Ksenija Geršak
|
4,868 |
| 204. |
J3-3314 |
Genetic factors and hormones in metabolic diseases |
7/1/2001
-
6/30/2004 |
PhD Andreja Kocijančič
|
5,192 |
| 205. |
L1-3261 |
Development of biologicaly active peptidomimetics |
7/1/2001
-
12/31/2003 |
PhD Uroš Urleb
|
2,149 |
| 206. |
V4-0476 |
Ekotoksikološki, rezidualni in ekonomski vidiki uporabe avermektinskih zdravil pri drobnici (Slovene) |
1/1/2002
-
10/31/2003 |
PhD Vesna Cerkvenik Flajs
|
5,024 |
| 207. |
L1-2129 |
Raziskave uporabnost proste površinske energije pri trdnih farmacevtskih sistemih (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Franc Vrečer
|
2,405 |
| 208. |
L3-2003 |
Razvoj rutinskih metod za dolocanje presnovkov galaktoze in genotipizacijo galaktozemij (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Tadej Battelino
|
3,307 |
| 209. |
L1-1381 |
Biofarmacevtske lastnosti, sinteza in aktivnost spojin kinolonov s kovinskimi atomi (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Albin Kristl
|
5,258 |
| 210. |
L4-1301 |
Proučevanje aktualnih kužnih bolezni pri živalih z uporabo sodobnih imunoloških, biokemijskih in molekularnih metod (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Darja Barlič Maganja
|
9,235 |
| 211. |
J2-1537 |
Reološke lastnosti in ostali transportni procesi hidrofilnih polimerov (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Miha Žumer
|
3,294 |
| 212. |
J1-0572 |
Interakcije bioaktivnih ligandov v sistemih rastoče kompleksnosti (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Aleš Mrhar
|
5,768 |
| 213. |
L4-0827 |
Tkivne kulture za proizvodnjo sekundarnih metabolitov (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Jana Žel
|
3,232 |
| 214. |
J1-7377 |
Protivirusne spojine: transport in interakcije v biosistemih (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Albin Kristl
|
2,753 |
| 215. |
J3-7880 |
Ugotavljanje biokemičnih in elektrofizioloških parametrov pri kronično bolnih otrocih in mladostnikih (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Ciril Kržišnik
|
6,095 |
| 216. |
V4-9128 |
Uporaba rastlinske biotehnologije za varstvo rastlin (razvoj identifikacijskih metod za rastlinske patogene in ovrednotenje transgenih (Slovene) |
10/1/1997
-
9/30/2000 |
PhD Maja Ravnikar
|
6,728 |
| 217. |
L1-0469 |
Optimization of MDP and TNF analogues having therapeutic potential |
7/1/1998
-
6/30/2000 |
PhD Anton Štalc
|
6,667 |
| 218. |
J1-8889 |
Mimetics of biologically active peptides: Strategies of design and synthesis |
1/1/1997
-
12/31/1999 |
PhD Danijel Kikelj
|
4,040 |
| 219. |
J1-8891 |
Synthesis, identification, and properties of potential pharmaceuticals |
1/1/1997
-
12/31/1999 |
PhD Andrej Petrič
|
1,916 |
| 220. |
L1-8890 |
Raziskave hidrodinamsko uravnoteženih farmacevtskih oblik z nadzorovanim sproščanjem (Slovene) |
1/1/1997
-
12/31/1998 |
PhD Franc Vrečer
|
2,029 |
| 221. |
L4-7355 |
Alternativno koriščenje za slovenijo perspektivnih zdravilnih in aromatičnih rastlin in njihovo vrednotenje (Slovene) |
1/1/1996
-
12/31/1998 |
PhD Dea Baričevič
|
1,705 |
| 222. |
L1-7823 |
Lastnosti in sinteza organokovinskih spojin z biološko učinkovitostjo (Slovene) |
1/1/1996
-
12/31/1998 |
PhD Stanislav Primožič
|
6,855 |
| 223. |
L2-7632 |
Spektralno selektivne energetsko efektne prevleke za solarne namene (Slovene) |
1/1/1996
-
12/31/1998 |
PhD Boris Orel
|
2,502 |
| 224. |
L1-7379 |
Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene) |
1/1/1996
-
6/30/1998 |
PhD Anton Štalc
|
6,387 |
| 225. |
J1-7053 |
Selektivni ligandi: sinteza, interakcije z makromolekulami in transport v biosistemih (Slovene) |
1/1/1995
-
6/30/1998 |
PhD Aleš Mrhar
|
7,255 |
| 226. |
J3-7200 |
Uporabnost kvalitativne metode za vrednotenje bolnikovega jemanja zdravil (Slovene) |
1/1/1995
-
6/30/1998 |
PhD Jelka Šmid-Korbar
|
568 |
